Lataa...
Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes
Type 2 diabetes mellitus (T2DM) is a progressive condition requiring long-term treatment. Most patients with T2DM are unable to maintain normoglycemia using metformin alone; thus, combination therapy is a pivotal part of disease management. Addition of the dipeptidyl peptidase-4 inhibitor linaglipti...
Tallennettuna:
| Julkaisussa: | Clin Med Insights Endocrinol Diabetes |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Libertas Academica
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4284079/ https://ncbi.nlm.nih.gov/pubmed/25628514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMED.S10360 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|